Is the case when the MA holder has delivered their complete stock of medicinal product XY to distributors and does not have any product XY available in the warehouse itself, considered to be suspended marketing?

Suspended marketing is considered to be a situation when the MA holder stops to secure the medicinal product for the needs of patients in the Czech Republic through its deliveries in adequate quantities and time intervals with a view to the current situation in the distribution chain in a manner compliant with the conditions stipulated by Section 33, paragraph 3(g), item 3 of the Act on Pharmaceuticals.